Meanwhile, MADD expression levels can be assessed using qPCR or ELISA, and its specific splice variants are expected to serve as prognostic indicators for intrahepatic cholangiocarcinoma, aiding in evaluating tumor malignancy and metastatic potential (83). Here, MADD is linked to intrahepatic cholangiocarcinoma.